Search

Search Results

• Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.

  Emanuele Cencini, Alberto Fabbri, Umberto Arrigucci, Alfonso Cerase, Monica Bocchia

  e2017040

  2017-06-16

  https://doi.org/10.4084/mjhid.2017.040

  3348

  PDF: 1028

  HTML: 1005

  Figure 1: 170

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

  Michele Bibas, Shayna Sarosiek , Jorge Castillo

  e2025015

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.015

  2521

  PDF: 1991

  HTML: 205

• HOW I TREAT FEBRILE NEUTROPENIA

  Marcio Nucci

  e2021025

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.025

  6615

  PDF: 3899

  HTML: 427

• TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS

  Lanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, Federico Giannoni

  e2013072

  2013-11-19

  https://doi.org/10.4084/mjhid.2013.072

  3032

  PDF: 1024

  HTML: 3078

• MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

  Alfredo Marzano

  e2009025

  https://doi.org/10.4084/mjhid.2009.025

  840

  PDF: 486

  HTML: 1303

• ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Murat Akova

  e2017002

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.002

  4084

  PDF: 1240

  HTML: 1955

  Table 1: 195

• HEPATITIS C VIRUS INFECTION AND LYMPHOMA

  Emmanuel Bachy, Caroline Besson, Felipe Suarez, Olivier Hermine

  e2010004

  2010-03-25

  https://doi.org/10.4084/mjhid.2010.004

  998

  PDF: 537

  HTML: 7810

• ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE

  Lijie Ma, Ling Chen

  e2026034

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.034

  139

  PDF: 163

  Suppl. Files: 31

  HTML: 20

• PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Isidro Jarque, Miguel Salavert, Javier Pemán

  e2016035

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.035

  3686

  PDF: 1236

  HTML: 3889

  Untitled: 211

  Untitled: 258

• Elevated endogenous alveolar carbon monoxide concentration in patients with transfusion-dependent thalassemia and its relation to ineffective erythropoiesis

  Yanni Xie

  e2025047

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.047

  580

  PDF: 434

  HTML: 33

• IMPORTANCE OF SOURCE CONTROL IN THE SUBGROUP OF INTRA-ABDOMINAL INFECTIONS FOR SEPTIC SHOCK PATIENTS: ANALYSIS OF 390 CASES

  Uğur Önal, Deniz Akyol, Olcay Buse Kenanoğlu, Merve Mert, Dilşah Başkol, Seichan Chousein Memetali, Gamze Şanlıdağ, Cansu Bulut, Arda Kaya, Ayşe Uyan Önal, Nazlıhan Yalçın, Günel Guliyeva, Şükrü Dirik, Oğuzhan Acet, Damla Akdağ, Melike Demir, Osman Bozbıyık, Berk Göktepe, Tufan Gümüş, İlkin Çankayalı, Kubilay Demirağ, Mehmet Uyar, Hilal Sipahi, Hüseyin Aytaç Erdem, Meltem Işıkgöz Taşbakan, Bilgin Arda, Şöhret Aydemir, Sercan Ulusoy, Oğuz Reşat Sipahi

  e2024051

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.051

  1101

  PDF: 941

  HTML: 111

• Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

  Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun

  e2022025

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.025

  1755

  PDF: 570

  HTML: 282

• TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA

  Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti

  e2014005

  2014-01-02

  https://doi.org/10.4084/mjhid.2014.005

  3321

  PDF: 1470

  HTML: 3999

• EVALUATION OF ORAL DOXYCYCLINE, AZITHROMYCIN, OR SEQUENTIAL DOXYCYCLINE-AZITHROMYCIN TREATMENT FOR SCRUB TYPHUS-

  Hanchen Liu, Weizhen Wang, Yuqing Dong

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.020

  627

  PDF: 439

  HTML: 97

• CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

  Vincenzo De Sanctis

  e2020006

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.006

  4245

  PDF: 1517

  HTML: 447

• ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

  Jialian Li

  e2019036

  2019-06-24

  https://doi.org/10.4084/mjhid.2019.036

  1978

  PDF: 1447

  HTML: 226

• GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

  Laura Breda, Roberto Gambari, Stefano Rivella

  e2009008

  2009-11-16

  1279

  PDF: 423

  HTML: 2880

• ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

  Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca

  e2020075

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.075

  1510

  PDF: 1404

  HTML: 491

• HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

  Armando Tripodi

  e2024027

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.027

  997

  PDF: 1346

  HTML: 130

• DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE

  Zeno Bisoffi, Federico Gobbi, Dora Buonfrate, Jef Van den Ende

  e2012036

  2012-05-09

  https://doi.org/10.4084/mjhid.2012.036

  3607

  PDF: 1108

  HTML: 23337

• ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica

  e2010026

  2010-08-31

  https://doi.org/10.4084/mjhid.2010.026

  1367

  PDF: 756

  HTML: 942

• THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis

  Kun Yang, Jian Xiao

  e2024001

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.001

  1377

  PDF: 1415

  PDF: 1006

  HTML: 211

• LEVOFLOXACIN PROPHYLAXIS VERSUS NO PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA DURING POST-INDUCTION APLASIA: A SINGLE CENTER STUDY

  Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio

  e2023022

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.022

  1569

  PDF: 1089

  HTML: 404

• HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

  Anna Maria Testi

  e2022038

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.038

  1118

  PDF: 766

  HTML: 208

• IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

  Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi

  e2017010

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.010

  3366

  PDF: 1280

  HTML: 2215

  Fi.1 Gritti.Rambaldi: 205

• PROPHYLACTIC ADMINISTRATION OF DOXYCYCLINE REDUCES CENTRAL VENOUS CATHETER INFECTIONS IN PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION

  Mohamed Kharfan-Dabaja, Mohamed Baydoun, Zaher Otrock, Samar Okaily, Rita Nehme, Racha Abu-Chahine, Ali Hamdan, Samar Noureddine, Souha Kanj, Zeina Kanafani, Ali Bazarbachi

  e2013015

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.015

  1520

  PDF: 865

  HTML: 1389

• SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

  Matteo Molica

  e2024079

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.079

  942

  PDF: 513

  HTML: 193

• RECENT ADVANCES IN THE 5Q- SYNDROME

  Andrea Pellagatti, Jacqueline Boultwood

  e2015037

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.037

  2775

  PDF: 1812

  HTML: 3666

  Pellagatti Fig 1: 214

  Pellagatti Fig. 2: 210

• Isavuconazole successfully treated pulmonary mucormycosis in acute myeloid leukemia: A case report

  Hong Chen, Kun Chen, wenqiang kong

  e2025031

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.031

  844

  PDF: 733

  HTML: 81

• AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

  Fabienne McClanahan, Peter Dreger

  e2012071

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.071

  2430

  PDF: 810

  HTML: 1672

• A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

  Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci

  e2023012

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.012

  882

  PDF: 940

  HTML: 412

• Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome

  ELPIS MANTADAKIS

  e2018018

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.018

  3526

  PDF: 984

  HTML: 425

  Table 1.: 226

• VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

  Ashraf Tawfik Soliman

  e2013057

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.057

  2720

  PDF: 1077

  HTML: 2571

• CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

  Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi

  e2009030

  https://doi.org/10.4084/mjhid.2009.030

  1277

  PDF: 606

  HTML: 3078

• Neutropenıa Secondary to Sars-Cov2 Vaccınatıon in Post-Hematopoıetıc Stem Cell Transplant (Hsct) Patıents

  LUIS MIGUEL JUAREZ-SALCEDO, Samantha Feijóo, Cristina García, Alejandro Alonso, Beatriz Aguado, Javier Ortiz, Angela Figuera, Rafael de la Cámara

  e2023014

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.014

  953

  PDF: 916

  HTML: 357

• THE CLINICAL SIGNIFICANCE OF THE SPECTRUM OF INTERACTIONS OF THE RARE IVS-II-5 G>C (HBB: C.315+5 G>C) VARIATION WITH OTHER Β-THALASSEMIA MUTATIONS IN SOUTHERN CHINA

  Yali Zhou, Guiping Liao, Xiaolin Yin, Sheng He, Yi Wu, Jian Xiao, Zhili Geng, Qiuying Huang, Ganghui Luo, Kun Yang

  e2022034

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.034

  914

  PDF: 511

  HTML: 313

• ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

  Maria L. Delioukina, Stephen J. Forman

  e2010018

  2010-06-30

  https://doi.org/10.4084/mjhid.2010.018

  1232

  PDF: 788

  HTML: 540

• BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA

  Alzbeta Zavrelova, Jakub Radocha, Pavla Paterova, Pavel Zak, Benjamin Visek, Martin Sima

  e2023001

  2022-12-31

  https://doi.org/10.4084/MJHID.2023.001

  1219

  PDF: 1097

  HTML: 436

• PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

  Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel

  e2020072

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.072

  1085

  PDF: 762

  HTML: 292

• CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

  Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri

  e2024038

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.038

  2574

  PDF: 1178

  HTML: 107

• THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

  Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri

  e2022012

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.012

  1775

  PDF: 2657

  HTML: 361

• How I treat acute and persistent sickle cell pain

  Samir Ballas

  e2020064

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.064

  1922

  PDF: 1115

  HTML: 485

• MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

  Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi

  e2012032

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.032

  2693

  PDF: 1006

  HTML: 2265

• Immune thrombocytopenic purpura cases following COVID-19 vaccination.

  Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida

  e2021047

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.047

  1106

  PDF: 430

  HTML: 318

• Emerging cases of pertussis among early infants born to unvaccinated mothers, an infectious disease long absent in Northwestern Greece

  Alexandros Makis, Vasileios Grammeniatis, Charis Galati, Panagiota Kostara, Evangelia Petridou, Constantina Gartzonika, Athanasios Pappas, Nikolaos Chaliasos

  e2017043

  2017-06-20

  https://doi.org/10.4084/mjhid.2017.043

  2843

  PDF: 651

  HTML: 347

• PATIENTS WITH ? 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE

  Simone Baldini, Luigi Rigacci, Valentina Carrai, Renato Alterini, Rajmonda Fjerza, Alberto Bosi

  e2012044

  2012-06-28

  https://doi.org/10.4084/mjhid.2012.044

  1186

  PDF: 658

  HTML: 618

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  3877

  PDF: 1474

  HTML: 8513

• CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.

  Edoardo Olivari

  e2025079

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.079

  429

  PDF: 207

  Html: 58

• OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

  Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst

  e2023025

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.025

  1296

  HTML: 307

  PDF: 933

  Suppl. Files: 446

• BETA THALASSEMIA MAJOR IN A DEVELOPING COUNTRY: EPIDEMIOLOGICAL, CLINICAL AND EVOLUTIONARY ASPECT

  Mohamed Bejaoui, Naouel Guirat

  e2013002

  2013-01-01

  https://doi.org/10.4084/mjhid.2013.002

  1599

  PDF: 899

  HTML: 2481